David Zigdon

David Zigdon is the current CEO at MIGAL Galilee Research Institute. David has also previously served as a board member for Radiaction Ltd., Perflow Medical, and Vascular Graft Solutions.

David Zigdon has over 20 years of experience in the medical device industry. David began their career at Moebius Medical Ltd., where they worked for 10 years in sales and marketing. David then moved on to Belkin Laser Ltd., where they were responsible for business development and marketing.

In 2010, David Zigdon co-founded Perflow Medical, a company that develops and manufactures minimally invasive devices for the treatment of vascular diseases. David served as a board member until the company was acquired by Vascular Graft Solutions in 2015.

After the sale of Perflow Medical, David Zigdon became a board member of Radiaction Ltd., a company that develops and manufactures radiation therapy equipment. David served in this role until October 2019, when they became the CEO of MIGAL Galilee Research Institute.

David Zigdon's educational career includes earning a BA from Bar-Ilan University in Economics, Accounting, and then an LLM from the same school in Law.

Jamal Mahajna - Director of Nutrition and Natural Products Department, Dror Noy - Director of Biotechnology Department, and Snait Tamir - Representative of Tel Hai College report to David Zigdon.